Viewing Study NCT01573702


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-07-07 @ 2:27 AM
Study NCT ID: NCT01573702
Status: COMPLETED
Last Update Posted: 2021-01-12
First Post: 2012-04-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non small cell lung cancer View
None EGFR mutant View
None Phase II View
None erlotinib View
None tarceva View
None cyberknife View
None Lineberger View